Labcorp EBIT 2010-2024 | LH

Labcorp EBIT for the quarter ending September 30, 2024 was $0.254B, a 0.71% increase year-over-year.

  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.
  • Labcorp 2021 EBIT was 3.049B, a 24.67% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Labcorp EBIT 2010-2024 | LH

  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.
  • Labcorp 2021 EBIT was 3.049B, a 24.67% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M